Search -

July 06, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Conference News LINC 2023

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

June 08, 2023

News Daily News

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

June 05, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

May 30, 2023

News Daily News

FDA Extends Dapagliflozin Indication Across LVEF Spectrum

May 09, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

January 17, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

December 14, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

September 23, 2022

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

August 23, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

August 15, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

June 09, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

April 29, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

February 24, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

February 22, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

January 17, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

December 21, 2021

News Daily News

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

December 20, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout